Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Recruiting · NCT06965322 · Observational (researchers observe without assigning treatment) · Lead sponsor: Medical University Innsbruck
View the official record on ClinicalTrials.gov →What this trial is about
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
- Residence in Austria
- Signed and dated consent of the patient in accordance with ICH-GCP guidelines
Exclusion criteria
- pregnancy
- age below 18 years
- Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Where it is running
1 location listed.
- Medical University Innsbruck - Innsbruck, Austria, Austria